Cargando…

An overview of HCV molecular biology, replication and immune responses

Hepatitis C virus (HCV) causes acute and chronic hepatitis which can eventually lead to permanent liver damage, hepatocellular carcinoma and death. Currently, there is no vaccine available for prevention of HCV infection due to high degree of strain variation. The current treatment of care, Pegylate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ashfaq, Usman A, Javed, Tariq, Rehman, Sidra, Nawaz, Zafar, Riazuddin, Sheikh
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086852/ https://www.ncbi.nlm.nih.gov/pubmed/21477382 http://dx.doi.org/10.1186/1743-422X-8-161

Ejemplares similares

Lysosomotropic agents as HCV entry inhibitors
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Inhibition of HCV 3a core gene through Silymarin and its fractions
por: Ashfaq, Usman Ali, et al.
Publicado: (2011)

Post-transcriptional inhibition of hepatitis C virus replication through small interference RNA
por: Ali Ashfaq, Usman, et al.
Publicado: (2011)

Antiviral activity of Acacia nilotica against Hepatitis C Virus in liver infected cells
por: Rehman, Sidra, et al.
Publicado: (2011)

In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus
por: Javed, Tariq, et al.
Publicado: (2011)

Inhibition of full length Hepatitis C Virus particles of 1a genotype through small interference RNA
por: Ansar, Muhammad, et al.
Publicado: (2011)

Glycyrrhizin as antiviral agent against Hepatitis C Virus
por: Ashfaq, Usman A, et al.
Publicado: (2011)

In-vitro model systems to study Hepatitis C Virus
por: Ashfaq, Usman Ali, et al.
Publicado: (2011)

Inhibition of Hepatitis C Virus 3a genotype entry through Glanthus Nivalis Agglutinin
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Antiviral drugs against hepatitis C virus
por: Rehman, Sidra, et al.
Publicado: (2011)

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
por: Jahan, Shah, et al.
Publicado: (2011)

HCV Innate Immune Responses
por: Heim, Markus H.
Publicado: (2009)

Development of global consensus sequence of HCV glycoproteins involved in viral entry
por: Idrees, Sobia, et al.
Publicado: (2013)

HCV dsRNA-Activated Macrophages Inhibit HCV Replication in Hepatocytes
por: Wang, Yizhong, et al.
Publicado: (2015)

Expression of core antigen of HCV genotype 3a and its evaluation as screening agent for HCV infection in Pakistan
por: Yousaf, Muhammad Z, et al.
Publicado: (2011)

Identifying key genes and screening therapeutic agents associated with diabetes mellitus and HCV-related hepatocellular carcinoma by bioinformatics analysis
por: Sufyan, Muhammad, et al.
Publicado: (2021)

Structural analysis and epitope prediction of HCV E1 protein isolated in Pakistan: an in-silico approach
por: Idrees, Sobia, et al.
Publicado: (2013)

Silencing HCV Replication in Its Reservoir
por: Youssef, Samar Samir, et al.
Publicado: (2018)

Autophagy in HCV Replication and Protein Trafficking
por: Chu, Ja Yeon Kim, et al.
Publicado: (2021)

Huh-7 cell line as an alternative cultural model for the production of human like erythropoietin (EPO)
por: Kausar, Humera, et al.
Publicado: (2011)

Inhibition of the HCV Core Protein on the Immune Response to HBV Surface Antigen and on HBV Gene Expression and Replication In Vivo
por: Zhu, Wenbo, et al.
Publicado: (2012)

Screening of drug candidates against Endothelin-1 to treat hypertension using computational based approaches: Molecular docking and dynamics simulation
por: Fatima, Israr, et al.
Publicado: (2022)

Substituted imidazopyridines as potent inhibitors of HCV replication()
por: Vliegen, Inge, et al.
Publicado: (2009)

Overview of the Mutational Landscape in Primary Myelofibrosis and Advances in Novel Therapeutics
por: Gilani, Jaleed Ahmed, et al.
Publicado: (2019)

HCV Envelope protein 2 sequence comparison of Pakistani isolate and In-silico prediction of conserved epitopes for vaccine development
por: Idrees, Sobia, et al.
Publicado: (2013)

Biochemical characterization, cytotoxic, antimutagenic, anticancer and molecular docking studies on Tecomella undulata
por: Riaz, Sana, et al.
Publicado: (2022)

HCV-induced autophagosomes are generated via homotypic fusion of phagophores that mediate HCV RNA replication
por: Wang, Linya, et al.
Publicado: (2017)

The Insight of In Silico and In Vitro evaluation of Beta vulgaris phytochemicals against Alzheimer’s disease targeting acetylcholinesterase
por: Rehman, Sidra, et al.
Publicado: (2022)

Molecular screening of phytochemicals from Amelanchier Alnifolia against HCV NS3 protease/helicase using computational docking techniques
por: Khan, Mahim, et al.
Publicado: (2013)

Rituximab-Based Treatment, HCV Replication, and Hepatic Flares
por: Sagnelli, Evangelista, et al.
Publicado: (2012)

Small molecule inhibitors of HCV replication from Pomegranate
por: Reddy, B. Uma, et al.
Publicado: (2014)

An Efficient New Route to Dihydropyranobenzimidazole Inhibitors of HCV Replication
por: Parker, Matthew A., et al.
Publicado: (2010)

Nanobiotechnology in crop stress management: an overview of novel applications
por: Nawaz, Ahmad, et al.
Publicado: (2023)

Computer aided screening of Accacia nilotica phytochemicals against HCV NS3/4a
por: Khan, Mahim, et al.
Publicado: (2013)

DFT study of the therapeutic potential of phosphorene as a new drug-delivery system to treat cancer
por: Tariq, Amina, et al.
Publicado: (2019)

Molecular Biology of Rotavirus Entry and Replication
por: Ruiz, Marie Christine, et al.
Publicado: (2009)

Integrating Network Pharmacology and Molecular Docking Approaches to Decipher the Multi-Target Pharmacological Mechanism of Abrus precatorius L. Acting on Diabetes
por: Noor, Fatima, et al.
Publicado: (2022)

Attenuation of 40S Ribosomal Subunit Abundance Differentially Affects Host and HCV Translation and Suppresses HCV Replication
por: Huang, Jing-Ying, et al.
Publicado: (2012)

Silent damage? Occult HCV replication and histological disease may occur following apparent HCV clearance
por: Manickam, Cordelia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4muqubiom6v2otqgbffbjaf78n